Loading provider…
Loading provider…
Specialist in Bethesda, MD
NPI: 1104837442Primary Employer
Maryland Oncology Hematology P.A.
marylandoncology.com
HQ Phone
Get M.D. Linda's Phone Numberphone_androidMobile
Get M.D. Linda's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
1987 - 2022
DC State Medical License
1995 - 2020
MD State Medical License
DC State Medical License
National Capital Consortium
Fellowship • Hematology and Medical Oncology
1988 - 1991
Residency • Internal Medicine
1984 - 1987
SUNY Upstate Medical University
upstate.edu
Medical School
Until 1984
Pure Red Cell Aplasia After Chemotherapy for Hodgkin's Lymphoma: In Vitro Evidence for T Cell Mediated Suppression of Erythropoiesis and Response to Sequential Cyclosporin and Erythropoietin
Authors: Thomas J. Reid, Mark Mullaney, Linda M. Burrell, John Redmond, Mangan Kf
Publication Date: 1994-05
Diffuse Tumor Microembolism: A Rare Cause of a High-Probability Perfusion Scan
Authors: Clyde Belgrave
Journal: Chest
Authors: John Byrd
Journal: Am J Hematol
Lead Sponsor: National Cancer Institute (NCI)
Collaborators: NRG Oncology
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, BIOLOGICAL: Trastuzumab, RADIATION: Whole Breast Irradiation